Biovica specializes in innovative cancer treatment monitoring through its proprietary blood test, the DiviTum® TKa test. This test is specifically designed to assess disease progression by measuring cell proliferation from solid tumors, providing oncologists with critical information to make informed treatment decisions. The DiviTum® TKa test has shown promise in distinguishing patients with estrogen receptor-positive metastatic breast cancer who may benefit from endocrine therapy alone, as well as in evaluating treatment efficacy during the early weeks of therapy. Clinical studies have indicated that the test can serve as a prognostic tool both at baseline and during treatment with CDK4/6 inhibitors, highlighting its potential to monitor disease effectively.

The DiviTum® TKa test is not only valuable for oncologists but also for pharmaceutical companies and patients, as it aids in predicting responses to standard therapies, such as palbociclib, used in treating metastatic breast cancer. The encouraging results from various studies underscore the test's ability to provide timely insights into treatment efficacy, thereby enhancing the overall management of cancer care. Biovica's commitment to advancing cancer treatment monitoring is evident in its focus on developing technologies that empower healthcare professionals and improve patient outcomes.

Sweden

Biovica develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and predict patient outcomes. The company’s DiviTum™ TKa assay, a test for accurately measuring cell proliferation, has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. Biovica aims to make best-possible-treatment from day one a reality.

Biovica collaborates with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies. The company is ISO 13485 certified for Quality Management Systems. DiviTum™ is CE-labeled and MPA-registered.

Biovica

Company Details